Tiziana Life Sciences is trading at $1.13, up 7.62% in after-hours trading, with the move appearing primarily linked to broader biotech strength despite declines in major indexes.
- Tiziana Life Sciences gained 17.99% during the September 23, 2026 regular session.
- No new company-specific announcement was identified on September 23. The latest update said the INFORM-MS trial’s final patient visit was completed, with topline data expected in October.